Victoria Bunik | Biology | Innovative Research Award

Innovative Research Award

Victoria Bunik

Victoria Bunik
Affiliation Moscow State University
Country Russia
Scopus ID 7003933084
Documents 130
Citations 3,738
h-index 32
Subject Area Biology
Event Scientific World Research Awards
ORCID 0000-0002-2552-8560

Victoria Bunik is a researcher associated with biological sciences and neurochemical research at Moscow State University. Her scholarly work includes studies on metabolic regulation, mitochondrial biochemistry, neurodegenerative mechanisms, vitamin-dependent biochemical pathways, and molecular neurobiology.[1] Her publications demonstrate sustained contributions to biochemical and neurological research through interdisciplinary scientific investigations involving enzymatic regulation, metabolic disorders, and molecular therapeutic approaches.

Abstract

Victoria Bunik has contributed extensively to biological and neurochemical sciences through research involving mitochondrial metabolism, enzymatic regulation, vitamin-dependent biochemical processes, and neurological disorders. Her publications examine molecular mechanisms associated with epilepsy, neurodegeneration, metabolic adaptation, and cellular signaling pathways.[2] Her interdisciplinary studies integrate biochemical analysis with molecular biology approaches to investigate metabolic homeostasis and neurological function. The research output demonstrates sustained academic engagement in neurochemistry and molecular biology, contributing to scientific understanding of metabolic regulation and potential therapeutic pathways in complex neurological and biochemical disorders.

Keywords

Biology, Neurochemistry, Molecular Biology, Metabolic Regulation, Mitochondrial Biochemistry, Neurological Disorders

Introduction

Modern biological research increasingly focuses on understanding metabolic regulation and molecular signaling in neurological systems. Scientific investigations involving mitochondrial function and vitamin-dependent enzymatic activity are important for advancing biomedical knowledge.[3] Victoria Bunik’s work contributes to this area through studies examining neurochemical and biochemical pathways.

Research Profile

Her research profile reflects extensive publication activity in biology and neurochemistry with an h-index of 32 and more than 3,700 citations. Her academic contributions include journal articles and collaborative studies involving molecular biology, epilepsy research, mitochondrial metabolism, and vitamin-related biochemical regulation.[1]

Research Contributions

Victoria Bunik has contributed to studies involving pyruvate dehydrogenase regulation, protein acylation, epilepsy-related metabolism, and neurochemical responses to vitamins B1 and B6.[4] Her work also includes investigations into glutamate dehydrogenase activity and biochemical markers associated with neurological conditions.

Publications

  • “Pentylenetetrazole-Induced Seizures Are Increased after Kindling.”
  • “Thiamine-dependent Regulation of Mammalian Brain Pyridoxal Kinase.”
  • “Behavioral Impact of the Regulation of the Brain 2-Oxoglutarate Dehydrogenase Complex.”

Research Impact

The research conducted by Victoria Bunik contributes to scientific understanding of neurochemical regulation and metabolic adaptation in neurological systems. Her work has relevance for molecular medicine, neurodegenerative disease research, epilepsy studies, and biochemical therapeutic investigations.[5]

Award Suitability

Victoria Bunik’s sustained publication record, interdisciplinary biological research, and scholarly impact demonstrate suitability for recognition through the Innovative Research Award. Her scientific contributions support continued advancement in neurochemistry, metabolic biology, and molecular biomedical sciences.

Conclusion

The academic work of Victoria Bunik reflects consistent engagement in biological and neurochemical sciences through studies focused on metabolic regulation, molecular signaling, and neurological processes. Her research contributions continue to support scientific progress in molecular biology and neurochemistry.

References

  1. Elsevier. (n.d.). Scopus author details: Victoria Bunik, Author ID 7003 933084. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7003933084
  2. Bunik, V. et al. (2023). Pentylenetetrazole-Induced Seizures Are Increased after Kindling. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms241512405
  3. ORCID. (2026). Victoria Bunik Research Record.
    https://orcid.org/0000-0002-2552-8560
  4. Bunik, V. et al. (2022). Thiamine-dependent Regulation of Mammalian Brain Pyridoxal Kinase. Journal of Neurochemistry.
    https://doi.org/10.1111/jnc.15576
  5. Bunik, V. et al. (2010). Behavioral Impact of the Regulation of the Brain 2-Oxoglutarate Dehydrogenase Complex.
    https://doi.org/10.4061/2010/749061

Kai Yuan | Biology | Research Excellence Award

Assoc. Prof. Dr. Kai Yuan | Biology | Research Excellence Award

Associate Professor | Peking University | China

Assoc. Prof. Dr. Kai Yuan is an internationally recognized researcher at Peking University whose work significantly advances neuroscience, psychiatric epidemiology, molecular signaling, and translational mental health research. With an exceptional 8,438 citations, 244 Scopus-indexed documents, and a strong h-index of 47, he stands among the most impactful scholars in neurobiology and psychiatric disorder research. His research interests span addiction memory consolidation, brain network dynamics, fMRI-based cognitive and emotional processing, depression and anxiety burden forecasting, cancer cell signaling, neuroimmune mechanisms, and human behavior under stress. Dr. Yuan’s research skills are wide-ranging and include advanced neuroimaging analytics, molecular and cellular assays, biomarker profiling, psychophysiological modeling, machine-learning–based disease prediction, and multidisciplinary clinical collaboration, often demonstrated through publications in high-impact journals such as Nature Communications, Translational Psychiatry, BMC Medicine, Communications Biology, and Journal of Affective Disorders. Although Scopus Preview does not list formal award entries, Dr. Yuan’s prolific productivity, more than 980 global co-authors, and consistent contributions to open-access, high-visibility research reflect his standing as a leading scientist whose work is frequently recognized by the international research community. His studies on psychiatric disorder mechanisms, memory retrieval-extinction processes, cancer proliferation pathways, and long-term cognitive outcomes of viral infections directly support advancements in clinical treatment strategies, public health decision-making, and precision medicine. In conclusion, Dr. Kai Yuan’s research continues to shape global understanding of the human brain and mental health, providing foundational insights that drive innovation across neuroscience, psychiatry, and biomedical science, while strengthening the scientific infrastructure for future therapeutic breakthroughs.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

  1. Yu, Y. F., Jia, T. Y., Lin, X., Bao, Y. P., Chang, S. H., Sun, J., Gao, T., Shi, J., Ai, S. Z., & Yuan, K.* (2025). Unveiling causal relationship between white matter tracts and psychiatric disorders. Communications Biology, 8(1), 1221.

  2. Xu, A., Yuan, K.#, Xue, S., Lu, W., Wu, X., Liu, W., Xue, Q., Liu, L., Hu, J., Guo, L., Zhang, Y., Hu, X., Chun Wong, G. T., Lu, L., & Huang, C. (2025). Laminin–dystroglycan mediated ferroptosis in hemorrhagic shock and reperfusion-induced cognitive impairment through AMPK/Nrf2. Free Radical Biology and Medicine, 230, 1–16.

  3. Chen, X., Li, Z., Han, Y., Yang, L., Han, Q., Cao, L., Guan, X., Liu, S., Meng, S., Liu, X., Lu, L., Zhang, Z., & Yuan, K.* (2025). A coordinated and enhanced brain network supports the persistence of long-term cocaine memory. Translational Psychiatry, 15(1), 444.

  4. Liu, X.#, Yuan, K.#, Lu, T., Lin, X., Zheng, W., Xue, Y., Shi, J., Lu, L., & Han, Y. (2023). Preventing incubation of drug craving to treat drug relapse: From bench to bedside. Molecular Psychiatry, 28(4), 1415–1429.

  5. Yue, J. L.#, Yuan, K.#, Bao, Y. P., Meng, S. Q., Shi, L., Fang, Q., Guo, X. J., Cao, L., Sun, Y. K., Lu, T. S., Zeng, N., Yan, W., Han, Y., Sun, J., Shi, J., Kosten, T. R., Xue, Y. X., Wu, P., & Lu, L.* (2022). [Title missing—please provide the exact article title to complete APA formatting]. EBioMedicine, 85, 104283.

Assoc. Prof. Dr. Kai Yuan’s pioneering research at the intersection of neuroscience, psychiatry, and translational medicine is advancing global understanding of brain circuitry, mental health disorders, and addiction biology. His work contributes to science by uncovering causal neural mechanisms that shape cognition, behavior, and psychiatric vulnerability, supports society through improved diagnostics and therapeutic strategies for depression, addiction, and neurological injury, and drives global innovation by integrating advanced neuroimaging, molecular signaling, and computational analytics to inform next-generation precision mental healthcare.

 

Aniket Gade | Biology | Best Researcher Award

Dr. Aniket Gade | Biology | Best Researcher Award

Associate Professor | Institute of Chemical Technology | India

Dr. Aniket Krishnarao Gade, affiliated with the Institute of Chemical Technology, Mumbai, India, is a prominent researcher in nanotechnology, green chemistry, and sustainable agriculture. He has earned recognition for his extensive contributions to eco-friendly synthesis of metallic and metal-oxide nanoparticles using plant extracts and microbial systems, advancing applications in environmental remediation, crop protection, and biomedical fields. Dr. Gade’s educational background includes a strong foundation in chemical technology and nanoscience, enabling him to integrate interdisciplinary approaches in his research. Professionally, he has developed multifunctional nanomaterials such as Ag-doped ZnO and iron oxide nanoparticles for photocatalytic degradation of environmental pollutants, antimicrobial and antifungal activity, and anticancer therapies, while also exploring innovative solutions in sustainable agriculture through carbon nanodots and pycnidia-forming fungi to enhance crop yield, fertilizer efficiency, and pest management with minimal ecological impact. His research interests encompass nanomaterial synthesis, theranostic nanomedicine, environmental nanotechnology, and agricultural nanobiotechnology, reflecting a commitment to solving real-world challenges through sustainable science. Dr. Gade possesses advanced research skills in nanoparticle fabrication, characterization techniques, biosensor development, and interdisciplinary experimental design, demonstrating a balance of fundamental and applied expertise. Throughout his career, he has received multiple awards and honors recognizing his scientific innovation and impact in nanotechnology and green chemistry. With a prolific record of 122 documents indexed in Scopus, over 15,234 citations, and an h-index of 43, his work has influenced a broad spectrum of scientific studies and applications. In conclusion, Dr. Gade’s career exemplifies a harmonious blend of research excellence, innovation, and societal relevance, making him a leading figure in sustainable nanotechnology and its applications in agriculture, environment, and human health.

Profiles: Scopus | ORCID | Google Scholar

Featured Publications

  1. Sah, P. M., Gite, S. G., Naik, H. S., Sonawane, R., Nadrowska, J., Golińska, P., Raut, R. W., & Gade, A. K. (2025). Ag-doped ZnO nanoparticles: A versatile multifunctional nanomaterial for anticancer, antibacterial, and recyclable photocatalyst. IEEE Transactions on NanoBioscience.

  2. Rai, M., Shende, S. S., Gade, A. K., Prokisch, J., & Avila-Quezada, G. D. (2025). Carbon nanodots for crop protection and fertilizer use in agriculture. BioNanoScience.

  3. Deshmukh, F., Kiran, K., Pawar, S. V., Nawani, N., Golińska, P., Gade, A., Ingle, P., & Gaikwad, S. C. (2025). Efficient photocatalytic degradation of azo dyes using Achyranthes aspera-mediated magnetic iron oxide nanoparticles: A green synthesis approach. Sustainable Chemistry for the Environment.

  4. Raut, R. W., Naik, H. S., Sah, P. M., Golińska, P., & Gade, A. (2025). A comparative analysis of optical biosensors for rapid detection of SARS‐CoV‐2 and influenza. Biotechnology and Bioengineering.

  5. Shende, S. S., Gade, A. K., Minkina, T. M., Ingle, P. U., Rajput, V. D., Sushkova, S. N., Mandzhieva, S. S., Rai, M., & Wong, M. H. (2024). Exploring sustainable management by using green nano-silver to combat three post-harvest pathogenic fungi in crops. Discover Nano.